Media Summary: Clemens Utschig-Utschig CTO, Boehringer Ingelheim Scientists at CU Anschutz are leveraging the power of new Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores
Towards Drug Design On Quantum Computers - Detailed Analysis & Overview
Clemens Utschig-Utschig CTO, Boehringer Ingelheim Scientists at CU Anschutz are leveraging the power of new Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores